Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study

Qiankun Chen, Zhengjiang Wei, Leying Wang, Xizhan Xu, Zhenyu Wei, Panpan Zheng, Kai Cao, Zijun Zhang, Kexin Chen, Qingfeng LiangFrontiers in Medicine 2022 · DOI

TL;DR

This study reveals that patients with schizophrenia have a higher prevalence of dry eye disease (DED), often presenting with subtle symptoms but clear clinical signs. The tears of these patients show a distinct inflammatory profile, with elevated levels of various cytokines, suggesting a link between schizophrenia, ocular surface inflammation, and DED.

What Problem Does This Paper Address?

Dry eye disease (DED) is a common ocular surface condition characterized by tear film instability, inflammation, and neurosensory abnormalities. While DED is often associated with symptoms, it's known that symptoms and signs don't always align. Previous research has explored links between DED and other mental health conditions like depression and anxiety. However, the specific relationship between DED and schizophrenia, a severe psychotic disorder marked by cognitive and emotional disruptions, remained largely uninvestigated at a molecular level. This paper aims to bridge this gap by examining the clinical features and inflammatory markers of DED in patients with schizophrenia compared to a control group.

Methods

This was a case-control study involving 40 patients with schizophrenia and 20 healthy controls. The researchers employed a multi-pronged approach to assess DED:

  • Symptom and Depression Assessment: The modified self-rating depression scale (M-SDS) and the ocular surface disease index (OSDI) were used to gauge depression symptoms and DED symptom severity, respectively.
  • Ocular Surface Evaluation: A battery of objective tests was performed, including:
  • Lipid layer thickness (LLT)
    • Partial blink rate (PBR)
    • Meibomian gland loss (MGL)
    • Tear break-up time (TBUT)
    • Corneal fluorescein staining (using the Oxford scheme)
    • Schirmer I-test (to measure tear production)
    • Eyelid margin abnormalities assessment
  • Tear Cytokine Analysis: A multiplex ELISA Quantibody array was used to measure the levels of various inflammatory cytokines, chemokines, and matrix metalloproteinases in tear samples. This allowed for a comprehensive molecular profiling of the ocular surface environment.

Datasets

Not discussed in the paper. The study utilized data collected from participants directly.

Key Insights and Ideas

  • Asymptomatic DED in Schizophrenia: A striking finding is that while patients with schizophrenia reported fewer DED symptoms (lower OSDI scores), they exhibited more pronounced objective signs of DED, such as increased meibomian gland loss and reduced tear break-up time. This highlights a significant disconnect between subjective experience and objective pathology in this population.
  • Inflammatory Fingerprint: The tears of schizophrenic patients showed a significantly altered cytokine profile. There was a marked increase in pro-inflammatory cytokines (like IL-1α, IL-6, IL-17A) and Th1/Th2 cytokines, alongside elevated levels of chemokines and MMP-9. Conversely, some anti-inflammatory markers (IL-1Ra) and matrix metalloproteinase inhibitors (TIMP-1, TIMP-2) were decreased. This suggests a chronic inflammatory state on the ocular surface.
  • Potential Role of Medications: The study acknowledges that antipsychotic medications, commonly used in schizophrenia treatment, can have ocular side effects. While not directly tested, this is a potential contributing factor to the observed DED signs.
  • Cytokine-Clinical Correlations: Interesting correlations were found between specific tear cytokines and clinical DED parameters in schizophrenic patients. For example, CCL2 levels correlated with OSDI, and ICAM-1 correlated with partial blink rate, suggesting these molecules might play a role in the manifestation or severity of DED in this group.

Key Results

  • Clinical Manifestations: Schizophrenic patients had significantly lower OSDI scores (median 0.0 vs. 7.3) and TBUT (median 4.5s vs. 10.0s) compared to controls. However, meibomian gland loss (MGL) was significantly higher (36.5% vs. 8.5%). A substantial majority (90%) of schizophrenic patients showed DED signs without significant symptoms, compared to 25% in controls. Eyelid margin irregularity was also more common in the schizophrenia group.
  • Cytokine Expression: Key pro-inflammatory cytokines (IL-1α, IL-6, IL-11, IL-12A, IL-15, IL-17A, G-CSF), Th1 cytokines (IL-1β, TNF-α, IFN-γ), Th2 cytokines (IL-4, IL-5, IL-13), and chemokines (CCL2, CCL4, CCL5, CCL11, CCL15, IL-8, CXCL9, CXCL10) were significantly elevated in the tears of schizophrenic patients. MMP-9 and ICAM-1 were also higher, while IL-1Ra, TIMP-1, and TIMP-2 were lower.
  • Correlations: CCL2 in tears positively correlated with OSDI. IL-5 and IL-13 positively correlated with TBUT. TIMP-1 and IL-5 correlated with LLT. ICAM-1 positively correlated with PBR. IL-8 showed a negative correlation with the Schirmer I-test.

Limitations and Future Work

The authors acknowledge several limitations:

  • Ethical Constraints: The study could not directly compare tear cytokines with blood cytokines due to ethical issues.
  • Medication Effects: All schizophrenic patients were on antipsychotic medication, making it difficult to isolate the effects of schizophrenia itself from medication side effects.
  • Smoking Prevalence: A higher proportion of schizophrenic patients in the study were smokers, which is a known risk factor for DED.
  • Sample Size: The study had a relatively small sample size, particularly for the control group.

Future work should include:

  • Prospective Studies: Larger, prospective studies are needed to confirm these findings.
  • Untreated Patients: Investigating DED and cytokine profiles in untreated schizophrenic patients would help disentangle the effects of the illness from its treatment.
  • Mechanism Exploration: Further research is required to fully elucidate the mechanisms by which schizophrenia and its treatments contribute to ocular surface inflammation and DED.

Summary updated

Abstract

Patients with schizophrenia were more likely to experience asymptomatic DED, with mild symptoms and obvious signs. The inflammatory cytokines in the tears of schizophrenic patients differed greatly from that of non-schizophrenic patients.
BibTeX
@inproceedings{chen2022dry,
  author = {Qiankun Chen and Zhengjiang Wei and Leying Wang and Xizhan Xu and Zhenyu Wei and Panpan Zheng and Kai Cao and Zijun Zhang and Kexin Chen and Qingfeng Liang},
  title = {{Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study}},
  booktitle = {Frontiers in Medicine},
  year = {2022},
  doi = {10.3389/fmed.2022.831337},
}
Figure